TipRanks
Go Ultimate55% OFF

Estrella Immunopharma (ESLA) Income Statement

Estrella Immunopharma Income Statement

Last quarter (Q2 2026), Estrella Immunopharma's total revenue was $0.00. In Q2, Estrella Immunopharma's net income was $-2.31M. See Estrella Immunopharma’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Jun 24Dec 22Dec 21
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
$ 13.06M$ 8.85M$ 7.31M$ 11.11M$ 1.69M
Depreciation and Amortization$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
$ -13.06M$ -8.85M$ -7.31M$ -11.11M$ -1.69M
$ -13.06M$ -8.85M$ -7.31M$ -11.11M$ -1.69M
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
$ -13.06M$ -8.85M$ -7.31M$ -11.11M$ -1.69M
$ -13.06M$ -8.85M$ -7.31M$ -11.11M$ -1.69M
Per Share Metrics
Basic EPS$ -0.35$ -0.24$ -0.21$ -0.32$ -0.05
Diluted EPS$ -0.35$ -0.24$ -0.21$ -0.32$ -0.05
Weighted Average Shares Outstanding36.82M36.68M35.20M35.20M35.20M
Weighted Average Shares Outstanding (Diluted)36.82M36.68M35.20M35.20M35.20M

Currency in USD

Estrella Immunopharma Earnings and Revenue History

-15M-10M-5M00 %0.4 %0.8 %1.2 %EarningsProfit Margin202020212022202320242025RevenueEarningsProfit Margin